• 1
    Aschan J, Lonnqvist B, Ringd NO, Kumlien G, Gahrton G. Graft-versus-myeloma effect. Lancet 1996;3468.
  • 2
    Verdonck LF, Lokhorst HM, Dekker AW, Nieuwenhuis HK, Petersen EJ. Graft-versus-myeloma effect in two cases. Lancet 1996;347:8001.
  • 3
    Lokhorst HM, Schattenberg A, Cornelissen JJ, Thomas LL, Verdonck LF. Donor leukocyte infusion are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood 1997;90:420611.
  • 4
    Lim SH, Wang Z, Chiriva-Internati M, Xue Y. Sperm protein 17 (Sp17) is a novel cancer-testis (CT) antigen in multiple myeloma. Blood 2001;97:150810.
  • 5
    Chiriva-Internati M, Wang Z, Xue Y, Bumm K, Hahn AB, Lim SH. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk. Eur J Immunol 2001;31:227783.
  • 6
    Noto H, Takahashi T, Makiguchi Y, Hayashi T, Hinoda Y, Imai K. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin. Int Immunol 1997;9:7918.
  • 7
    Corradini P, Ladetto M, Voena C et al. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood 1993;15:270813.
  • 8
    Olds LJ, Chen YT. New paths in human cancer serology. J Exp Med 1998;187:11637.
  • 9
    Lim SH, Austin S, Owen-Jones E, Robinson L. Expression of testicular genes in haematological malignancies. Br J Cancer 1999;81:11624.
  • 10
    Van Baren N, Brasseur F, Godelaine D et al. Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood 1999;94:115664.
  • 11
    Lea IA, Adoyo P, O'Rand MG. Autoimmunogenicity of the human sperm protein Sp17 in vasectomized men and identification of linear B cell epitopes. Fertil Steril 1997;67:35561.
  • 12
    Landowski TH, Gleason-Guzman MC, Dalton WS. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 1997;89:185461.
  • 13
    Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS. Mutation in the Fas antigen in patients with multiple myeloma. Blood 1997;90:426670.
  • 14
    Kataoka T, Shinohara N, Takayama H et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996;156:367886.
  • 15
    Lacy HM, Sanderson RD. Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell–cell adhesion. Blood 2001;98:21605.